Citation: | Tengfei Li, Kaijun Sun, Wanchun Yang, Meiling Zhang, Wentao Feng, Siliang Chen, Mingrong Zuo, Qiuyun Yuan, Yanhui Liu, Mina Chen. MEOX2 promotes glioma growth and temozolomide chemoresistance[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2023.12.002 |
C. Rouse, H. Gittleman, Q.T. Ostrom, et al., Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010, Neuro. Oncol. 18 (2016) 70−77.
|
D.N. Louis, A. Perry, P. Wesseling, et al., The 2021 WHO Classification of Tumors of the Central Nervous System: a summary, Neuro. Oncol. 23 (2021) 1231−1251.
|
T. Li, W. Yang, M. Li, et al., Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide, Cancer Cell Int. 20 (2020), 65.
|
J. Wang, Y. Chen, Q. Wang, et al., MEOX2-mediated regulation of Cathepsin S promotes cell proliferation and motility in glioma, Cell Death Dis. 13 (2022), 360.
|
A. Schonrock, E. Heinzelmann, B. Steffl, et al., MEOX2 homeobox gene promotes growth of malignant gliomas, Neuro. Oncol. 24 (2022) 1911−1924.
|